Review: n-3 polyunsaturated fatty acids reduce fatal MI, sudden death, and overall mortality in coronary heart disease
- Decline in rate of death from ischaemic heart disease in the United Kingdom. Heller, R.F.; Hayward, D.; Hobbs, M.S.T. // British Medical Journal (Clinical Research Edition);1/22/1983, Vol. 286 Issue 6361, p260
Examines the decline of mortality rate from ischaemic heart disease in Great Britain. Ratio of polyunsaturated to saturated fat; Comparison between the tobacco consumption of men and women; Difference between the fat intake of men and women.
- Fish Consumption and Coronary Heart Disease Mortality in Finland, Italy, and the Netherlands. Oomen, Claudia M.; Feskens, Edith J. M.; Räsänen, Leena; Fidanza, Flaminio; Nissinen, Aulikki M.; Menotti, Alessandro; Kok, Frans J.; Kromhout, Daan // American Journal of Epidemiology;2000, Vol. 151 Issue 10, p999
Fish consumption seems to protect against death from coronary heart disease (CHD). If this association is due to n-3 polyunsaturated fatty acids, especially fatty fish may be responsible for this protective effect. The association between total, lean, and fatty fish consumption and the risk of...
- Does a short course of clarithromycin affect mortality in patients with stable coronary artery disease? Kendall, Claire // CMAJ: Canadian Medical Association Journal;2/28/2006, Vol. 174 Issue 5, p622
The article focuses on a study that investigated the role of clarithromycin in the mortality of patients with stable coronary artery disease in Copenhagen, Denmark. The patients were randomly assigned to receive either clarithromycin or placebo for two weeks. The limitations of the study include...
- Effect of PUFAs on chronic head failure. // Infectious Disease Alert;Dec2008 Clinical Briefs in Primary, p24
The article discusses research being done on polyunsaturated fatty acids (PUFA). It references a study published in the 2008 issue of "Lancet." It examines the impact of PUFA on patients with chronic heart failure (CHF). CHF patients were enrolled in a randomized placebo-controllled trial. It...
- Food and heart disease. // British Medical Journal (Clinical Research Edition);9/1/1984, Vol. 289 Issue 6444, p543
Presents recommendations for the prevention of coronary heart diseases. Increase in the ratio of polyunsaturated fatty acids; Reduction of the dietary cholesterol; Need for simple labelling codes in food containers.
- Reduced trans fatty acid intake decreases the frequency of coronary heart disease in adults. // European Journal of Pediatrics;2001, Vol. 160 Issue 8, pB516
Presents information on a study which investigated the association between the decrease in trans fatty acid with the decrease in the rate of coronary heart disease in the Netherlands. Sources of unsaturated fatty acids; Study population and methods; Trans fatty acid intake in the Netherlands.
- C-reactive protein and n—3 fatty acids in patients with a previous myocardial infarction. Madsen, Trine; Christensen, Jeppe H.; Schmidt, Erik B. // European Journal of Nutrition;Oct2007, Vol. 46 Issue 7, p428
Dietary intake of the marine long-chain nâ€“3 polyunsaturated fatty acids (PUFA) may reduce mortality after a myocardial infarction (MI). This may partly be attributed to their anti-inflammatory properties. To investigate the effect of nâ€“3 PUFA on C-reactive protein (CRP) in patients...
- The International Salt Secret That Could Save Your Heart -- and Your Life. Wright, Jonathan V. // Townsend Letter;May2010, Issue 322, p72
The article discusses the importance of the reduction of unsaturated and saturated fat ratio in the daily diet of patients with heart diseases to the decreased death rates of Finnish people from stroke. It mentions that the diet changes have reduced death rates of around 85 per cent to 90 per...
- Effect of PUFAs on chronic heart failure. // Clinical Cardiology Alert;Dec2008 Clinical Briefs in Primary, Vol. 13 Issue 12, p24
The article focuses on a study which examines the effects of n-3 polyunsaturated fatty acids (PUFAs) in patients with chronic heart failure (CHF). It states that this study was participated by CHF patients who were enrolled in a randomized placebo-controlled trial of 1 gram per day PUFAs. It...